Trial Details

COMPLETED
Basic Information
Clinical ID c4604
Identifier NCT00268879
Trial Title Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Renzapride
Participant Information
Sponsor Alizyme
City Cambridge
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2005-12
Primary Completion Date 2008-01
Completion Date 2008-01